What is the ticker symbol for Pluri?

Pluri trades under the ticker PLUR on NASDAQ.

What sector does Pluri operate in?

Pluri is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PLUR in a portfolio?

PortView shows PLUR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Pluri (PLUR) Stock Analysis

NASDAQHealthcareBiotechnology

$1.45-0.68%

1-year price historyRange $1.46 – $5.15

52-week range$1.45

$1.41$5.29

What Pluri does

Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology. A key candidate, PLX-PAD, is in advanced clinical development, with ongoing Phase III trials for muscle recovery after hip fracture surgery, Phase II studies for acute respiratory distress syndrome associated with COVID-19, and Phase I/II trials for steroid-refractory Graft-versus-Host Disease. Additionally, Pluri is advancing PLX-R18, a treatment designed to aid in incomplete hematopoietic recovery following hematopoietic cell transplantation and to address acute radiation syndrome. The company rebranded to Pluri Inc. in July 2022, having previously operated as Pluristem Therapeutics Inc.

Key metrics

Market cap

$15.64M

P/E (TTM)

-0.32

EPS (TTM)

$-4.53

Beta

0.67

Dividend yield

0.00%

Revenue / share

$0.11

50-day avg

$1.77

200-day avg

$2.85

52-week high

$5.29

52-week low

$1.41

CEO

Yaacov Yanay

ETFs linked to PLUR

Broad-market and Healthcare sector ETFs an investor holding Pluri is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PLUR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PLUR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Pluri?: Pluri trades under the ticker PLUR on NASDAQ.
Which exchange is PLUR listed on?: PLUR is listed on NASDAQ.
What sector does Pluri operate in?: Pluri is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PLUR in a portfolio?: PortView shows PLUR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.